Hepatitis B, Jamaica
Hepatitis B, Jamaica @hepatitisb_biz: Hepatitis B symptoms in men/women, screening/diagnosis, testing/check and treatment, Jamaica - Private and confidential service.
Keywords: Hepatitis B Jamaica, Jamaica Hepatitis B, Hepatitis B.
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hepatitis B, Jamaica
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Budget airlines based in Singapore: Budget airlines operating in Singapore:
Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.
[Articles] HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study
Tue, 21 Oct 2014 06:15:31 +0100 | The Lancet Infectious Diseases
Screening for viral hepatitis is important in individuals diagnosed as HIV positive. Effective management for viral hepatitis should be integrated into HIV treatment programmes. Long-term data are needed about the effect of hepatitis co-infection on HIV disease progression. (Source: The Lancet Infectious Diseases)
[Comment] Hepatitis virus and HIV interactions
Tue, 21 Oct 2014 06:15:01 +0100 | The Lancet Infectious Diseases
Because of shared routes of transmission, 5–25% of the 34 million people with HIV worldwide are co-infected with either hepatitis B virus (HBV), hepatitis C virus (HCV), or both, with the highest number of co-infections in low-income countries. The negative effect of HIV infection on the progression of HBV and HCV infection is well established, with high rates of viral persistence, higher hepatitis viral load, and a more rapid progression to liver fibrosis and hepatocellular carcinoma in HIV-positive patients. (Source: The Lancet Infectious Diseases)
Vaccines and MS
Sun, 19 Oct 2014 23:00:00 +0100 | Multiple Sclerosis Trust
A study found no association between hepatitis B and human papillomavirus (HPV) vaccines and an increased risk of MS up to three years after vaccination.
Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.
Fri, 17 Oct 2014 00:00:00 +0100 | The British Journal of Nutrition
Authors: Fiorino S, Bacchi-Reggiani L, Sabbatani S, Grizzi F, di Tommaso L, Masetti M, Fornelli A, Bondi A, de Biase D, Visani M, Cuppini A, Jovine E, Pession A
Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta‐analysis
Thu, 16 Oct 2014 00:00:00 +0100 | Journal of Gastroenterology and Hepatology
ConclusionsThe resistance mutations occurred frequently in untreated CHB patients, especially in China. The lamivudine resistance had the highest natural prevalence rate, while other nucleos(t)ide analogues showed rarely spontaneous resistance. Detecting the spontaneous resistance mutations will benefit the clinical management of CHB patients. (Source: Journal of Gastroenterology and Hepatology)
Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion
Thu, 16 Oct 2014 00:00:00 +0100 | Journal of Clinical Pathology
The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long‐term nucleos(t)ide analogue therapy
Tue, 14 Oct 2014 09:17:46 +0100 | Alimentary Pharmacology and Therapeutics
ConclusionsIn this Canadian study of nucleos(t)ide analogues‐treated patients with chronic hepatitis B, the incidence of HCC was lower than expected, suggesting that NA reduce the risk of chronic hepatitis B‐related HCC. (Source: Alimentary Pharmacology and Therapeutics)
The serum IL‐23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B
Tue, 14 Oct 2014 00:00:00 +0100 | Liver International
ConclusionsA high pre‐treatment serum IL‐23 level predicts the therapeutic response in HBeAg‐positive CHB patients during PegIFN therapy.This article is protected by copyright. All rights reserved. (Source: Liver International)
Characteristics and clinical outcome of nonsteroidal anti-inflammatory drug-induced acute hepato-nephrotoxicity among Chinese patients.
Tue, 14 Oct 2014 00:00:00 +0100 | World Journal of Gastroenterology : WJG
CONCLUSION: The injury typically occurred after an overdose of NSAIDs. The risk factors include age older than 60 years, alcohol use, positive HBV markers, extracellular volume depletion and RAAS inhibitor combined use.
Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series
Tue, 14 Oct 2014 00:00:00 +0100 | Journal for Immunotherapy of Cancer